HRAS and non-small cell lung carcinoma: Consistent with the high prevalence of KRAS mutations in human colon and NSCLC tumors, 12 of the 20 models evaluated had KRAS mutations in codons G12, G13, G61 or A146T, whereas no NRAS or HRAS mutations were detected.